UNRESECTABLE HEPATOCELLULAR CARCINOMA
Clinical trials for UNRESECTABLE HEPATOCELLULAR CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new UNRESECTABLE HEPATOCELLULAR CARCINOMA trials appear
Sign up with your email to follow new studies for UNRESECTABLE HEPATOCELLULAR CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Liver cancer drug combo safety checked in 1,200 patients
Disease control CompletedThis study looked at the safety of two drugs (IMJUDO and IMFINZI) given together or alone to 1,200 people with advanced liver cancer that cannot be removed by surgery. The goal was to track side effects in real-world use, not to cure the disease. Participants received these treat…
Matched conditions: UNRESECTABLE HEPATOCELLULAR CARCINOMA
Sponsor: AstraZeneca • Aim: Disease control
Last updated May 26, 2026 03:54 UTC
-
New injection shows promise for untreatable liver cancer
Disease control CompletedThis early-stage study tested a new drug called NRT6003 in 40 adults with liver cancer that cannot be surgically removed. The main goals were to check safety and see if the injection shrinks liver tumors. Researchers measured side effects and how long the tumors stayed under cont…
Matched conditions: UNRESECTABLE HEPATOCELLULAR CARCINOMA
Phase: PHASE1 • Sponsor: Chengdu New Radiomedicine Technology Co. LTD. • Aim: Disease control
Last updated May 22, 2026 14:04 UTC
-
New scan could sharpen view of liver cancer spread
Diagnosis CompletedThis study tested whether a special PET scan using a radioactive tracer (68Ga-PSMA) can improve how doctors see and manage advanced liver cancer that has spread. 29 adults with liver cancer not treatable by surgery or transplant took part. The scan targets a protein common on liv…
Matched conditions: UNRESECTABLE HEPATOCELLULAR CARCINOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Diagnosis
Last updated May 26, 2026 03:54 UTC